Rajiv Patni - 15 Feb 2024 Form 3 Insider Report for Quince Therapeutics, Inc. (QNCX)

Role
Director
Signature
/s/ Brendan Hannah, Attorney-in-Fact
Issuer symbol
QNCX
Transactions as of
15 Feb 2024
Net transactions value
$0
Form type
3
Filing time
15 Feb 2024, 18:09:25 UTC
Previous filing
26 Sep 2023
Next filing
07 Jun 2024

No securities are beneficially owned.